ICC ICC Labs Inc

ICC Labs Receives Additional Land From the Government of Uruguay to Increase Its Production Capacity at Its Psychoactive Facility

ICC Labs Receives Additional Land From the Government of Uruguay to Increase Its Production Capacity at Its Psychoactive Facility

VANCOUVER, British Columbia, June 26, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that the Government of Uruguay through its regulatory authority IRCCA (Cannabis Regulation and Control Institute) has granted the Company an additional land package of approximately 55,000 square foot in order to increase its production capacity.

“A relevant milestone that demonstrates the confidence that the Government has placed in our Company to continue executing the terms of our recreational cannabis license granted for 5 years on January 14, 2016,” commented Alejandro Antalich, Chief Executive Officer of ICC Labs.

ABOUT ICC LABS INC.

ICC Labs is a fully licensed producer and distributor of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products in Uruguay as well as a fully licensed producer of medicinal cannabis in Colombia. The Company has active operations in Uruguay, and is focused on becoming the worldwide leading producer of cannabinoid extracts, giving support and promoting responsible use for medicinal purposes, backed by scientific research and innovation, while following strict compliance with standards for quality and safety.

For more information, please visit .

Contact:

ICC Labs Inc.

Alejandro Antalich, Chief Executive Officer

t: 598-2900-0000 ext. 404

e:  

Neither the TSX Venture Exchange (the “TSX-V”) nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s future production and sales, results of operations, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements.

Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to: receipt of the requisite regulatory approvals required, including from the IRCCA for increased production, ability to construct additional greenhouses and to scale its production. Additional information identifying risks and uncertainties is contained in the Company’s filings with Canadian securities regulators, and available at Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.

A photo accompanying this announcement is available at

EN
26/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICC Labs Inc

 PRESS RELEASE

ICC Labs Obtains Final Order For Arrangement With Aurora Cannabis

ICC Labs Obtains Final Order For Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC) (TSX-V: ICC) is pleased to announce that the Supreme Court of British Columbia has issued a final order (the Final Order) approving the plan of arrangement (the Arrangement) between ICC and Aurora Cannabis Inc. (Aurora) (TSX: ACB, NYSE: ACB). Subject to the terms and conditions of an arrangement agreement between ICC and Aurora dated September 8, 2018 (the Arrangement Agreement), Aurora will acquire all of the issued and outsta...

 PRESS RELEASE

ICC Labs Announces Shareholder Approval of Arrangement With Aurora Can...

ICC Labs Announces Shareholder Approval of Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC) (TSX-V: ICC) is pleased to announce that, at the special meeting of shareholders of ICC (ICC Shareholders) held today (the Meeting), ICC Shareholders overwhelmingly voted in favour of a special resolution (the Arrangement Resolution) to approve the previously announced plan of arrangement (the Arrangement) between ICC and Aurora Cannabis Inc. (Aurora) (TSX: ACB, NYSE: ACB). Subject to the terms and conditions of an ar...

 PRESS RELEASE

Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition o...

Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC Milestone towards Completing Transaction to Establish Leadership in South American Market EDMONTON, Alberta and VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (Aurora) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (ICC) (TSX-V: ICC) are pleased to announce that Aurora has received, from its consortium of lenders led by Bank of Montreal (collectively, the Lenders), consent and approval as required under its credit agreement with the Lenders to the previou...

 PRESS RELEASE

ICC Labs Provides Information About Circular

ICC Labs Provides Information About Circular VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (ICC or the Company) (TSX-V: ICC) confirms that the management information circular dated October 3, 2018 (the Circular), form of proxy and other materials with respect to the Company’s proposed plan of arrangement (the Arrangement) with Aurora Cannabis Inc. (Aurora) have been mailed to holders (the ICC Shareholders) of common shares of ICC (the ICC Shares) of record as of September 26, 2018 in accordance with an interim order of the Supreme Court of British Columbia. ...

 PRESS RELEASE

ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis

ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC Labs) (TSX-V: ICC) is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia authorizing, among other things, the holding of the Company’s special meeting of holders (the ICC Shareholders) of common shares (ICC Shares). At the meeting, the ICC Shareholders will be asked to consider and vote on a special resolution (the Arrangement Resolution) approving a statutory plan of arrangement...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch